Contact

Strategic Negotiation Services

Licensing & Collaboration Negotiations

For over a decade, I have led deals negotiations for a wide range of in-/out-licensing and collaboration agreements for a leading Big Pharma company.

What I delivered

  • Rapid diagnostic of internal alignment, risks, and deal-breaking assumptions
  • Clarification of each stakeholder’s priorities, sensitivities, and boundaries
  • Definition of a unified negotiation strategy catering to needs and interests from all stakeholders involved
  • Scenario modeling (best case, base case, walk-away)
  • Scripts, framing tools, and talking points for key negotiation moments (calls, virtual meetings, face-to-face interactions, etc.)
  • Tactical planning and rehearsal sessions for leadership

Outcome

Successful closing of over 60 deals with a value over 10B CHF across the entire value chain (early research & development up to commercial opportunities, drug delivery, data & AI, etc. ) and across a wide range of therapeutic areas (oncology, neuroscience, immunology, cardiovascular and metabolic diseases, rare diseases, infectious diseases, etc.).

Feedback

Chief Business Officer, Boston-based Biotech

Working with Valérie fundamentally changed the way we approached the negotiation of a complex early-stage licensing and collaboration agreement. She brought in a level of clarity, structure and momentum, which was critical throughout the deal. From day one, she listened deeply—beyond what was said in the room—to understand our pressures, constraints, and the nuances of our partner’s position.

What set Valérie apart was her collaborative, no-nonsense style. She came with creative, well-reasoned solutions that worked for both sides, helping us overcome sticking points that had blocked progress for months. She kept momentum high, and she helped us negotiate constructively without ever losing sight of the business objectives.

In the end, we secured a deal that exceeded expectations for both parties. I would work with her again without hesitation.

CEO and Founder of a Bay-Area based biotech company

Valérie has an exceptional ability to listen, cut through complexity, and craft solutions that work for both sides. Her structured, collaborative, no-nonsense approach helped us close a deal in an efficient and constructive manner.

Investor, European-based Rare Disease Investment Fund

Valérie’s neutrality and systems-dynamics thinking sharpened our decision-making. She sees how incentives, risks, and dependencies interact across a rare disease portfolio—and translates that complexity into clear, unbiased strategic choices. Invaluable support for any investor navigating high-stakes collaborations.

Founder, European-based AI/Advanced Analytics company

Although external circumstances ultimately prevented the deal from closing, working with Valérie was exceptional. She expertly navigates complex stakeholder dynamics, balances interests with tact and clarity, and keeps momentum even in uncertain conditions. Highly recommended for any high-stakes, multi-party negotiation.

Offering
Contact